Literature DB >> 3342843

Regional blood flow in resting and stimulated sciatic nerve of diabetic rats.

W W Monafo1, S G Eliasson, S Shimazaki, H Sugimoto.   

Abstract

The role of ischemia in the pathogenesis of diabetic peripheral neuropathy remains uncertain. We used the distribution of [14C]butanol to measure resting regional sciatic nerve blood flow in normal, anesthetized rats and in rats with acute experimental diabetes from streptozotocin administration. Regional flows in hind limb biceps femoris muscle and skin were simultaneously measured. In additional diabetic rats, these blood flows were compared in both limbs after proximal electrical stimulation of one sciatic trunk (10 shocks/s) for 15 min. One month after streptozotocin administration, 8 of 11 test rats were hyperglycemic. Resting nerve blood flow in the hyperglycemic rats--5.6 +/- 3.07 ml.min-1.100 g-1--was significantly less than that in the controls (9.4 +/- 3.9 ml.min-1.100 g-1, P = 0.002). Muscle blood flow was normal and skin blood flow decreased in these rats. Calculated tissue vascular resistances were elevated in all three tissues. Stimulation of one sciatic trunk in five other diabetic rats resulted in a stimulated nerve blood flow of 15.7 +/- 7.7 ml.min-1.100 g-1, and nerve blood flow in the resting control limb was 7.7 +/- 4.3 ml.min-1.100 g-1 (P = 0.009). Muscle blood flow increased approximately fourfold on the stimulated side but skin blood flow did not increase. Resting sciatic nerve blood flow is modestly decreased in acute streptozotocin-induced diabetes, but the neural blood vessels are still responsive to the increase in nerve metabolic activity associated with nerve stimulation.

Entities:  

Mesh:

Year:  1988        PMID: 3342843     DOI: 10.1016/0014-4886(88)90177-x

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  19 in total

Review 1.  Vascular factors in diabetic neuropathy.

Authors:  S Tesfaye; R Malik; J D Ward
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

2.  Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.

Authors:  E K Maxfield; N E Cameron; M A Cotter; K C Dines
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

3.  Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.

Authors:  K C Dines; M A Cotter; N E Cameron
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

4.  Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization.

Authors:  N E Cameron; M A Cotter; K C Dines; E K Maxfield
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

5.  Diabetes mellitus prevents capsaicin from inducing hyperaemia in the rat sciatic nerve.

Authors:  D W Zochodne; L T Ho
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

6.  Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids.

Authors:  C Karasu; M Dewhurst; E J Stevens; D R Tomlinson
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

7.  Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models.

Authors:  E J Stevens; A L Carrington; D R Tomlinson
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

8.  Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; S Robertson
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

9.  Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter; E K Maxfield
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

10.  Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus.

Authors:  E J Stevens; M J Lockett; A L Carrington; D R Tomlinson
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.